NEW YORK, March 3, 2015 /PRNewswire/ -- Summary
GlobalData's clinical trial report, "Mucopolysaccharidosis I (MPS
I) (Hurler Syndrome) Global Clinical Trials Review, H1, 2015"
provides data on the Mucopolysaccharidosis I (MPS I) (Hurler
Syndrome) clinical trial scenario. This report provides elemental
information and data relating to the clinical trials on
Mucopolysaccharidosis I (MPS I) (Hurler Syndrome). It includes an
overview of the trial numbers and their recruitment status as per
the site of trial conduction across the globe. The databook offers
a preliminary coverage of disease clinical trials by their phase,
trial status, prominence of the sponsors and also provides briefing
pertaining to the number of trials for the key drugs for treating
Mucopolysaccharidosis I (MPS I) (Hurler Syndrome). This report is
built using data and information sourced from proprietary
databases, primary and secondary research and in-house analysis by
GlobalData's team of industry experts.
Note: Certain sections in the report may be removed or altered
based on the availability and relevance of data for the indicated
disease.
Scope
- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national
contributions in each
- Clinical trial (complete and in progress) data by phase, trial
status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and
terminated)
Reasons to buy
- Understand the dynamics of a particular indication in a condensed
manner
- Abridged view of the performance of the trials in terms of their
status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities /
Institutes / Hospitals or Companies
Read the full report:
http://www.reportlinker.com/p02133109-summary/view-report.html
About Reportlinker
ReportLinker is an award-winning market research solution that
finds, filters and organizes the latest industry data so you get
all the market research you need - instantly, in one place.
http://www.reportlinker.com
__________________________
Contact Clare: clare@reportlinker.com
US: (339)-368-6001
Intl: +1 339-368-6001
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/mucopolysaccharidosis-i-mps-i-hurler-syndrome-global-clinical-trials-review-h1-2015-300044887.html
SOURCE Reportlinker